The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
NYLI Healthy Hearts ETF HART
Morningstar’s Analysis HART
Will HART outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alphabet Inc Class A | 5.19 | 468,908 | Communication Services |
Abbott Laboratories | 5.09 | 459,918 | Healthcare |
Pfizer Inc | 5.01 | 453,387 | Healthcare |
UnitedHealth Group Inc | 5.01 | 453,224 | Healthcare |
Apple Inc | 5.01 | 453,099 | Technology |
Johnson & Johnson | 4.96 | 448,064 | Healthcare |
Novartis AG Registered Shares | 4.83 | 436,604 | Healthcare |
Eli Lilly and Co | 4.68 | 422,781 | Healthcare |
AstraZeneca PLC | 4.56 | 412,363 | Healthcare |
Novo Nordisk AS Class B | 4.32 | 390,635 | Healthcare |